Evangeline Motley-Johnson
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Muscle, Smooth, Vascular | 9 | 2007 | 130 | 1.340 |
Why?
|
| Nitric Oxide Synthase Type III | 4 | 2016 | 67 | 1.190 |
Why?
|
| Protein Kinase C | 5 | 2005 | 120 | 0.880 |
Why?
|
| Receptor, PAR-1 | 2 | 2016 | 10 | 0.880 |
Why?
|
| Angiotensin II | 5 | 2005 | 97 | 0.820 |
Why?
|
| Endothelial Cells | 3 | 2016 | 308 | 0.790 |
Why?
|
| Proto-Oncogene Proteins | 5 | 2003 | 239 | 0.640 |
Why?
|
| Receptor, PAR-2 | 2 | 2016 | 3 | 0.630 |
Why?
|
| Receptors, Thrombin | 1 | 2016 | 2 | 0.550 |
Why?
|
| Enzyme Activation | 7 | 2007 | 444 | 0.510 |
Why?
|
| Endothelium, Vascular | 3 | 2007 | 237 | 0.500 |
Why?
|
| Phosphorylation | 10 | 2016 | 928 | 0.490 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2016 | 173 | 0.490 |
Why?
|
| Mitogen-Activated Protein Kinases | 4 | 2004 | 136 | 0.420 |
Why?
|
| Insulin | 3 | 2003 | 236 | 0.410 |
Why?
|
| Calcium | 3 | 2007 | 480 | 0.390 |
Why?
|
| Thrombin | 2 | 2008 | 25 | 0.370 |
Why?
|
| Gene Expression Regulation | 2 | 2016 | 1015 | 0.370 |
Why?
|
| Phosphothreonine | 1 | 2008 | 5 | 0.340 |
Why?
|
| Cells, Cultured | 6 | 2016 | 1518 | 0.330 |
Why?
|
| Hydrogen Peroxide | 4 | 2004 | 190 | 0.310 |
Why?
|
| Rats, Sprague-Dawley | 8 | 2005 | 1618 | 0.300 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2005 | 86 | 0.300 |
Why?
|
| Rats | 10 | 2007 | 3483 | 0.290 |
Why?
|
| Aorta | 4 | 2015 | 167 | 0.280 |
Why?
|
| Insulin Antagonists | 2 | 2003 | 3 | 0.270 |
Why?
|
| Signal Transduction | 6 | 2007 | 1908 | 0.260 |
Why?
|
| Proto-Oncogene Proteins c-akt | 6 | 2015 | 269 | 0.250 |
Why?
|
| Molsidomine | 1 | 2003 | 4 | 0.240 |
Why?
|
| Serotonin Antagonists | 1 | 2003 | 23 | 0.230 |
Why?
|
| Serotonin | 1 | 2003 | 123 | 0.220 |
Why?
|
| Nitric Oxide Synthase | 1 | 2003 | 128 | 0.220 |
Why?
|
| Epidermal Growth Factor | 2 | 2004 | 68 | 0.220 |
Why?
|
| Lysophosphatidylcholines | 1 | 2002 | 22 | 0.210 |
Why?
|
| Animals | 15 | 2015 | 15081 | 0.200 |
Why?
|
| Reactive Oxygen Species | 3 | 2004 | 461 | 0.200 |
Why?
|
| Isoenzymes | 1 | 2002 | 161 | 0.200 |
Why?
|
| Acetylcysteine | 1 | 2001 | 62 | 0.180 |
Why?
|
| Protein Kinase C-alpha | 3 | 2007 | 10 | 0.180 |
Why?
|
| Hypoglycemic Agents | 1 | 2001 | 160 | 0.180 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2000 | 132 | 0.170 |
Why?
|
| 17-alpha-Hydroxypregnenolone | 1 | 1998 | 2 | 0.160 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 1998 | 24 | 0.160 |
Why?
|
| Adrenal Glands | 1 | 1998 | 19 | 0.160 |
Why?
|
| Cadmium Chloride | 1 | 1998 | 13 | 0.160 |
Why?
|
| Umbilical Veins | 2 | 2008 | 17 | 0.160 |
Why?
|
| Scavenger Receptors, Class B | 1 | 2015 | 8 | 0.130 |
Why?
|
| Quinazolines | 2 | 2008 | 33 | 0.130 |
Why?
|
| Lipoproteins | 1 | 2015 | 64 | 0.130 |
Why?
|
| Lipoproteins, HDL | 1 | 2015 | 46 | 0.130 |
Why?
|
| Botulinum Toxins | 2 | 2008 | 11 | 0.130 |
Why?
|
| Serine | 2 | 2007 | 75 | 0.130 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2015 | 83 | 0.120 |
Why?
|
| Cattle | 2 | 2007 | 477 | 0.120 |
Why?
|
| Nitric Oxide | 1 | 2016 | 316 | 0.110 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2015 | 1039 | 0.110 |
Why?
|
| Receptor, Insulin | 2 | 2003 | 25 | 0.110 |
Why?
|
| Precipitin Tests | 2 | 2001 | 52 | 0.100 |
Why?
|
| ADP Ribose Transferases | 2 | 2008 | 6 | 0.090 |
Why?
|
| rho-Associated Kinases | 2 | 2008 | 31 | 0.090 |
Why?
|
| rhoA GTP-Binding Protein | 2 | 2008 | 30 | 0.090 |
Why?
|
| Enzyme Inhibitors | 2 | 2003 | 433 | 0.090 |
Why?
|
| Time Factors | 3 | 2004 | 1742 | 0.080 |
Why?
|
| Genes, Dominant | 1 | 2008 | 18 | 0.080 |
Why?
|
| Nitrites | 1 | 2008 | 46 | 0.080 |
Why?
|
| Pyrroles | 1 | 2008 | 55 | 0.080 |
Why?
|
| Oligopeptides | 1 | 2008 | 102 | 0.080 |
Why?
|
| Blotting, Western | 2 | 2001 | 859 | 0.080 |
Why?
|
| Amides | 1 | 2008 | 68 | 0.080 |
Why?
|
| Pyridines | 1 | 2008 | 116 | 0.080 |
Why?
|
| Male | 4 | 2016 | 20025 | 0.070 |
Why?
|
| Protein Kinase C-delta | 1 | 2005 | 18 | 0.070 |
Why?
|
| p21-Activated Kinases | 1 | 2005 | 16 | 0.070 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 2005 | 23 | 0.070 |
Why?
|
| Young Adult | 1 | 2016 | 4268 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 2004 | 103 | 0.060 |
Why?
|
| Models, Biological | 1 | 2008 | 677 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 2 | 2004 | 99 | 0.060 |
Why?
|
| Platelet-Derived Growth Factor | 2 | 2001 | 26 | 0.060 |
Why?
|
| Peroxynitrous Acid | 1 | 2003 | 6 | 0.060 |
Why?
|
| Catalase | 1 | 2004 | 109 | 0.060 |
Why?
|
| Feedback, Physiological | 1 | 2003 | 31 | 0.060 |
Why?
|
| Diamide | 1 | 2003 | 2 | 0.060 |
Why?
|
| Maleimides | 1 | 2003 | 13 | 0.060 |
Why?
|
| Superoxide Dismutase | 1 | 2004 | 155 | 0.060 |
Why?
|
| Drug Interactions | 1 | 2003 | 141 | 0.050 |
Why?
|
| Humans | 3 | 2016 | 37093 | 0.050 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 2002 | 9 | 0.050 |
Why?
|
| Indoles | 1 | 2003 | 158 | 0.050 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2001 | 41 | 0.050 |
Why?
|
| Aorta, Thoracic | 1 | 2001 | 28 | 0.050 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2001 | 20 | 0.050 |
Why?
|
| Middle Aged | 1 | 2016 | 10129 | 0.050 |
Why?
|
| Calcimycin | 1 | 2001 | 12 | 0.050 |
Why?
|
| Ionophores | 1 | 2001 | 12 | 0.050 |
Why?
|
| Tyrphostins | 1 | 2001 | 15 | 0.050 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2002 | 98 | 0.050 |
Why?
|
| Muscle, Smooth | 1 | 2001 | 58 | 0.050 |
Why?
|
| Enzyme Activators | 1 | 2000 | 12 | 0.050 |
Why?
|
| Immunoblotting | 1 | 2001 | 176 | 0.050 |
Why?
|
| Indicators and Reagents | 1 | 2000 | 58 | 0.050 |
Why?
|
| Oxidants | 1 | 2000 | 45 | 0.050 |
Why?
|
| Phosphoproteins | 1 | 2001 | 163 | 0.050 |
Why?
|
| Transcriptional Activation | 1 | 2001 | 172 | 0.050 |
Why?
|
| Adult | 1 | 2016 | 11712 | 0.040 |
Why?
|
| Pyrimidines | 1 | 2001 | 118 | 0.040 |
Why?
|
| GTP-Binding Proteins | 1 | 1999 | 60 | 0.040 |
Why?
|
| Biological Transport | 2 | 2015 | 185 | 0.040 |
Why?
|
| Actins | 1 | 1999 | 148 | 0.040 |
Why?
|
| Mice | 3 | 2015 | 5913 | 0.040 |
Why?
|
| Culture Media | 1 | 1998 | 90 | 0.040 |
Why?
|
| Antioxidants | 1 | 2001 | 416 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 1 | 1998 | 502 | 0.040 |
Why?
|
| Female | 1 | 2016 | 20969 | 0.030 |
Why?
|
| Apolipoprotein A-I | 1 | 2015 | 21 | 0.030 |
Why?
|
| Cell Polarity | 1 | 2015 | 54 | 0.030 |
Why?
|
| Cocaine | 1 | 1996 | 232 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2015 | 409 | 0.030 |
Why?
|
| Hippocampus | 1 | 1996 | 561 | 0.030 |
Why?
|
| Gene Expression | 1 | 2015 | 674 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2015 | 1609 | 0.020 |
Why?
|
| Superoxides | 1 | 2004 | 53 | 0.010 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2004 | 95 | 0.010 |
Why?
|
| Models, Cardiovascular | 1 | 2004 | 49 | 0.010 |
Why?
|
| Glutathione Peroxidase | 1 | 2004 | 111 | 0.010 |
Why?
|
| Models, Animal | 1 | 2004 | 134 | 0.010 |
Why?
|
| Cell Division | 1 | 2004 | 307 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2004 | 435 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2004 | 617 | 0.010 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1999 | 40 | 0.010 |
Why?
|
| Stress, Mechanical | 1 | 1999 | 113 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 1999 | 187 | 0.010 |
Why?
|
| Receptors, Dopamine | 1 | 1996 | 25 | 0.010 |
Why?
|
| DNA | 1 | 1999 | 574 | 0.010 |
Why?
|
| Long-Term Potentiation | 1 | 1996 | 102 | 0.010 |
Why?
|
| Behavior, Animal | 1 | 1996 | 314 | 0.010 |
Why?
|